Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.940
-0.010 (-0.25%)
Jul 6, 2026, 12:19 PM EDT - Market open
Eledon Pharmaceuticals Market Cap
Eledon Pharmaceuticals has a market cap or net worth of $304.57 million as of July 6, 2026. Its market cap has increased by 82.96% in one year.
Market Cap
304.57M
Enterprise Value
194.81M
1-Year Change
82.96%
Ranking
Category
Stock Price
$3.94
Market Cap Chart
Since May 11, 2017, Eledon Pharmaceuticals's market cap has increased from $44.66M to $304.57M, an increase of 581.98%. That is a compound annual growth rate of 23.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 304.57M | 168.40% |
| Dec 31, 2025 | 113.47M | -53.90% |
| Dec 31, 2024 | 246.13M | 465.07% |
| Dec 29, 2023 | 43.56M | 38.87% |
| Dec 30, 2022 | 31.37M | -50.29% |
| Dec 31, 2021 | 63.09M | -72.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 317.49M |
| Foghorn Therapeutics | 311.18M |
| Cartesian Therapeutics | 311.15M |
| Neumora Therapeutics | 309.42M |
| Bicycle Therapeutics | 303.68M |
| SAB Biotherapeutics | 299.74M |
| MacroGenics | 299.38M |
| Galectin Therapeutics | 297.01M |